Javascript must be enabled to continue!
Corticotropin-releasing hormone in melanoma and non-melanoma skin cancer
View through CrossRef
Abstract
Background
Corticotropin-releasing hormone (CRH) is involved in the regulation of immunological and cellular processes. Recently, CRH has been found to be expressed in skin cancers, where its expression appears to correlate with the degree of malignancy.
Objective
This study correlates CRH expression in melanoma metastases with patient survival and compares the intensity of CRH expression in melanoma to that in less aggressive skin cancer entities.
Methods
Tissue microarrays with cores from 94 melanomas and 40 melanocytic nevi and 51 slides from 41 basal cell carcinomas (BCC) and 10 squamous cell carcinomas (SCC) were immunohistochemically stained for CRH. The intensity of CRH expression in melanoma metastases was stratified by sex and correlated with patient survival. Furthermore, proliferation and apoptosis were assessed in CRH-stimulated A431 cells using enzyme-linked immunosorbent assays and an apoptosis detection kit.
Results
The intensity of CRH expression was higher in primary melanomas than in melanocytic nevi. Higher CRH expression was also found in melanoma metastases from women compared to men. However, higher CRH expression was correlated with reduced overall survival only in men. Compared to melanoma, BCCs and SCCs showed weaker CRH expression, which was in line with the finding that in vitro, CRH stimulation of the A431 cells reduced their proliferative activity.
Conclusion
CRH does not necessarily correlate with the degree of malignancy, as semi-malignant cancers such as BCC show higher levels of CRH expression than SCCs. In melanoma, CRH expression in metastases may be an important prognostic factor for overall survival in men, which needs further evaluation.
Statement of contribution
Marcel Mueller and Susanne Melchers performed all experiments and wrote the first draft of the manuscript. Iris Mueller helped with the experiments and reviewed the manuscript, Jochen Utikal assembled the tissue microarrays and reviewed the manuscript, Julia Krug helped with the figures and reviewed the manuscript, and Astrid Schmieder designed and supervised the project and corrected the manuscript.
Title: Corticotropin-releasing hormone in melanoma and non-melanoma skin cancer
Description:
Abstract
Background
Corticotropin-releasing hormone (CRH) is involved in the regulation of immunological and cellular processes.
Recently, CRH has been found to be expressed in skin cancers, where its expression appears to correlate with the degree of malignancy.
Objective
This study correlates CRH expression in melanoma metastases with patient survival and compares the intensity of CRH expression in melanoma to that in less aggressive skin cancer entities.
Methods
Tissue microarrays with cores from 94 melanomas and 40 melanocytic nevi and 51 slides from 41 basal cell carcinomas (BCC) and 10 squamous cell carcinomas (SCC) were immunohistochemically stained for CRH.
The intensity of CRH expression in melanoma metastases was stratified by sex and correlated with patient survival.
Furthermore, proliferation and apoptosis were assessed in CRH-stimulated A431 cells using enzyme-linked immunosorbent assays and an apoptosis detection kit.
Results
The intensity of CRH expression was higher in primary melanomas than in melanocytic nevi.
Higher CRH expression was also found in melanoma metastases from women compared to men.
However, higher CRH expression was correlated with reduced overall survival only in men.
Compared to melanoma, BCCs and SCCs showed weaker CRH expression, which was in line with the finding that in vitro, CRH stimulation of the A431 cells reduced their proliferative activity.
Conclusion
CRH does not necessarily correlate with the degree of malignancy, as semi-malignant cancers such as BCC show higher levels of CRH expression than SCCs.
In melanoma, CRH expression in metastases may be an important prognostic factor for overall survival in men, which needs further evaluation.
Statement of contribution
Marcel Mueller and Susanne Melchers performed all experiments and wrote the first draft of the manuscript.
Iris Mueller helped with the experiments and reviewed the manuscript, Jochen Utikal assembled the tissue microarrays and reviewed the manuscript, Julia Krug helped with the figures and reviewed the manuscript, and Astrid Schmieder designed and supervised the project and corrected the manuscript.
Related Results
Abstract LB163: Germline pathogenic variants in melanoma patients
Abstract LB163: Germline pathogenic variants in melanoma patients
Abstract
Background: The etiology of melanoma has generally been thought to be exposure to UV radiation (sun and sun tanning lamps). However, the percent of melanoma...
The Risk of Subsequent Invasive Melanoma after a Primary in Situ or Invasive Melanoma in a High Incidence Country (New Zealand)
The Risk of Subsequent Invasive Melanoma after a Primary in Situ or Invasive Melanoma in a High Incidence Country (New Zealand)
Abstract
Background
Patients with invasive melanoma are at increased risk of developing subsequent invasive melanoma, but the ri...
Precursors of skin melanoma (melanoma-sensitive nevi)
Precursors of skin melanoma (melanoma-sensitive nevi)
Interest in melanoma precursors, or melanoma-sensitive skin nevi, has not lost its relevance for many years due to the steady increase of skin melanoma morbidity in recent decades ...
Carbon footprint of non-melanoma skin cancer surgery
Carbon footprint of non-melanoma skin cancer surgery
Abstract
Background
Climate change poses a significant global health threat and healthcare, including surgery, contributes to gr...
Coexisting Granulomatous Mastitis and Breast Cancer: A Systematic Review
Coexisting Granulomatous Mastitis and Breast Cancer: A Systematic Review
Abstract
Introduction: Granulomatous mastitis (GM) is a rare inflammatory breast disease that mimics carcinoma. GM can coexist with breast cancer (BC), though the relationship rema...
SKIN CANCER SCOPING REVIEW
SKIN CANCER SCOPING REVIEW
Introduction: skin cancer is a pathology with an important frequency in the world, it is generally divided as non-melanoma skin cancer (NMSC) or melanoma. The exact incidence of sk...
Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract
Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
EPD Electronic Pathogen Detection v1
EPD Electronic Pathogen Detection v1
Electronic pathogen detection (EPD) is a non - invasive, rapid, affordable, point- of- care test, for Covid 19 resulting from infection with SARS-CoV-2 virus. EPD scanning techno...

